CemiplimabMyasthenia gravis, myocarditis and myositis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1818卷 / 1期

关键词：

D O I：

10.1007/s40278-020-82359-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：79 / 79

相关论文

共 50 条

[21] NivolumabMyasthenia gravis and myositis: case report
Reactions Weekly, 2019, 1776 (1) : 330 - 330
[22] Nivolumab/pembrolizumabDrug toxicity in the form of neurotoxicity, hepatotoxicity, myositis, myocarditis and myasthenia gravis: case report
Reactions Weekly, 2023, 1949 (1) : 346 - 346
[23] Surufatinib/tislelizumabAcute immune myocarditis, myositis and myasthenia gravis-like syndrome : case report
Reactions Weekly, 2023, 1964 (1) : 386 - 386
[24] AntineoplasticsMyasthenia gravis, myositis and myocarditis overlap syndrome: 7 case reports
Reactions Weekly, 2022, 1931 (1) : 80 - 80
[25] Epacadostat/pembrolizumabFatal myocarditis and myositis: case report
Reactions Weekly, 2019, 1764 (1) : 126 - 126
[26] Ipilimumab/nivolumabAcute myocarditis and myositis: case report
Reactions Weekly, 2017, 1654 (1) : 194 - 194
[27] PembrolizumabMyocarditis, myositis and myasthenia gravis: case report
Reactions Weekly, 2023, 1969 (1) : 308 - 308
[28] Ipilimumab/pembrolizumabMyasthenia gravis and myositis: case report
Reactions Weekly, 2018, 1728 (1) : 201 - 201
[29] AN ASSOCIATION OF THYMOMA MYASTHENIA-GRAVIS FOCAL NODULAR MYOSITIS ALOPECIA AND MYOCARDITIS - A CASE-REPORT
MACDERMOTT, N
IRISH JOURNAL OF MEDICAL SCIENCE, 1986, 155 (08) : 296 - 296
[30] PembrolizumabAutoimmune myositis and myasthenia gravis: case report
Reactions Weekly, 2018, 1706 (1) : 403 - 403

← 1 2 3 4 5 →